Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DERMAPIK

K-Number: K882360 · 1988-08-09

Decision Date1988-08-09
Product CodeSCL
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

DERMAPIK is the device name listed in this FDA 510(k) record. The listed applicant is Creative Scientific Equipment Corp.. It received FDA 510(k) clearance on 1988-08-09 under 510(k) number K882360. The device is classified under product code SCL. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DERMAPIK?

DERMAPIK is a medical device that received FDA 510(k) clearance on 1988-08-09. The listed applicant is Creative Scientific Equipment Corp.. The 510(k) number is K882360.

When did DERMAPIK receive FDA 510(k) clearance?

DERMAPIK received FDA 510(k) clearance on 1988-08-09, under 510(k) number K882360.

Who is the listed applicant for DERMAPIK?

The FDA 510(k) record lists Creative Scientific Equipment Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DERMAPIK?

The FDA product code for DERMAPIK is SCL.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: SCL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑